CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 25 of 48

Rheumatology (Oxford)

Briefs 961–1,000 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Evaluation of changes in cardiac longitudinal strain rate in patients with systemic sclerosis undergoing iloprost treatment: an observational study

    Cohort studySystemic sclerosis

  2. Rheumatology (Oxford)

    Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study

    Cohort studyVasculitis & PMR

  3. Rheumatology (Oxford)

    The implication of anti-Ro60 with or without anti-Ro52 antibody in patients with systemic lupus erythematosus

    Cohort studyLupus & APS

  4. Rheumatology (Oxford)

    Longitudinal analysis of serum urate in prediabetic phase

    Cohort studyGout & crystals

  5. Rheumatology (Oxford)

    Transiently increased circulating CD39+FoxP3+ Treg cells predicts the clinical response to methotrexate in early rheumatoid arthritis

    Cohort studyRA

  6. Rheumatology (Oxford)

    Muscle involvement in systemic sclerosis: high mortality not associated with nature of histological lesions

    Cohort studySystemic sclerosis

  7. Rheumatology (Oxford)

    Association of rare and common genetic variants in MOCOS with inadequate response to allopurinol

    Research articleGout & crystals

  8. Rheumatology (Oxford)

    Systemic sclerosis and cancer in the UK: an epidemiological analysis using the clinical practice research datalink

    Cohort studySystemic sclerosis

  9. Rheumatology (Oxford)

    Definitions of and instruments for disease activity, remission and relapse in polymyalgia rheumatica: a systematic literature review

    Research articleVasculitis & PMR

  10. Rheumatology (Oxford)

    A secukinumab dose-escalation study in patients with ankylosing spondylitis not achieving inactive disease after 16 weeks of treatment

    Randomized controlled trialSpondyloarthritis & PsA

  11. Rheumatology (Oxford)

    Prevalence and prognostic relevance of electrocardiographic abnormalities among patients with ANCA-associated vasculitis

    Cohort studyVasculitis & PMR

  12. Rheumatology (Oxford)

    Short- and long-term outcomes of patients with pure membranous lupus nephritis compared with patients with proliferative disease

    Cohort studyLupus & APS

  13. Rheumatology (Oxford)

    A predictive model for progression to clinical arthritis in at-risk individuals with arthralgia based on lymphocyte subsets and ACPA

    Diagnostic or prognostic studyRA

  14. Rheumatology (Oxford)

    Racial and ethnic associations with interstitial lung disease and healthcare utilization in patients with systemic sclerosis

    Cohort studySystemic sclerosis

  15. Rheumatology (Oxford)

    Validation of HAND OA US inflammatory and structural damage score (HOUSE) for thumb-base joints: systematic review on truth and discrimination

    Meta-analysisOsteoarthritis

  16. Rheumatology (Oxford)

    Circulating cell-free DNA promotes inflammation in dermatomyositis patients with anti-NXP2 antibodies via the cGAS/STING pathway

    Mechanistic studyMyositis

  17. Rheumatology (Oxford)

    CT-based comprehensive scoring system for assessing hip arthropathy in ankylosing spondylitis: feasibility study with clinical correlation

    Cohort studySpondyloarthritis & PsA

  18. Rheumatology (Oxford)

    Tendon involvement and its association with pain and hand function in patients with osteoarthritis of the hand

    Cross-sectional studyOsteoarthritis

  19. Rheumatology (Oxford)

    De novo manifestations during adalimumab treatment in Behçet’s syndrome

    Cohort studyVasculitis & PMR

  20. Rheumatology (Oxford)

    Association of rare single-nucleotide variant MUC5B rs35705950 with interstitial lung disease in Japanese rheumatoid arthritis

    Research articleRA

  21. Rheumatology (Oxford)

    Epidemiology of ANCA vasculitis in northern Spain

    Cohort studyVasculitis & PMR

  22. Rheumatology (Oxford)

    Kidney whole-transcriptome profiling in primary antiphospholipid syndrome reveals complement, interferons and NETs-related gene expression

    Mechanistic studyLupus & APS

  23. Rheumatology (Oxford)

    Relapses and serious adverse events during rituximab maintenance therapy in ANCA-associated vasculitis: a multicentre retrospective study

    Cohort studyVasculitis & PMR

  24. Rheumatology (Oxford)

    Changes of cerebral structure and perfusion in subtypes of systemic sclerosis: a brain magnetic resonance imaging study

    Cross-sectional studySystemic sclerosis

  25. Rheumatology (Oxford)

    Severe haematological involvement in children with systemic lupus erythematosus and clinical associations

    Cohort studyLupus & APS

  26. Rheumatology (Oxford)

    ANA-associated arthritis: clinical and biomarker characterization of a population for basket trials

    Cohort studyAcross diseases

  27. Rheumatology (Oxford)

    Management and outcomes of interstitial lung disease associated with anti-synthetase syndrome: a systematic literature review

    Meta-analysisMyositis

  28. Rheumatology (Oxford)

    Autoantibodies to joint-related peptides as predictive markers in early rheumatoid arthritis

    Diagnostic or prognostic studyRA

  29. Rheumatology (Oxford)

    Elicitation of expert prior opinion to design the BARJDM trial in juvenile dermatomyositis

    Research articlePediatric

  30. Rheumatology (Oxford)

    Granulomatosis with polyangiitis with and without antineutrophil cytoplasmic antibodies: a case-control study

    Case-control studyVasculitis & PMR

  31. Rheumatology (Oxford)

    Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project

    Research articlePediatric

  32. Rheumatology (Oxford)

    Improved diagnostic accuracy for polymyalgia rheumatica using FDG-PET/CT with clinical diagnosis or 2012 ACR/EULAR classification criteria

    Diagnostic or prognostic studyVasculitis & PMR

  33. Rheumatology (Oxford)

    A novel inhibitory pathway of synovial inflammation exerted by glucocorticoids and tumour necrosis factor inhibitors via lymphocyte activation gene-3 up-regulation: an ex vivo study

    Mechanistic studyRA

  34. Rheumatology (Oxford)

    Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study

    Cohort studyLupus & APS

  35. Rheumatology (Oxford)

    Sex differences in patient-reported outcome measures and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors

    Cohort studySpondyloarthritis & PsA

  36. Rheumatology (Oxford)

    TNF-alpha blockade in primary chronic non-bacterial osteomyelitis of the mandible

    Cohort studyAutoinflammatory & rare

  37. Rheumatology (Oxford)

    Enhanced surveillance for the detection of psoriatic arthritis in a UK primary care psoriasis population: results from the TUDOR trial

    Randomized controlled trialSpondyloarthritis & PsA

  38. Rheumatology (Oxford)

    Unveiling the dynamics of B lymphocytes in systemic lupus erythematosus patients treated with belimumab through longitudinal single-cell RNA sequencing

    Mechanistic studyLupus & APS

  39. Rheumatology (Oxford)

    Immunosuppressives discontinuation after renal response in lupus nephritis: predictors of flares, time to withdrawal and long-term outcomes

    Cohort studyLupus & APS

  40. Rheumatology (Oxford)

    Magnetic resonance imaging to monitor disease activity in giant cell arteritis treated with ultra-short glucocorticoids and tocilizumab

    Mechanistic studyVasculitis & PMR

All 1,905 Briefs in ExploreShowing Briefs 961–1,000 of 1,905, newest first